Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

HTLV-1 Proviral Load after Two Months' Treatment with Anti-CCR4 Monoclonal Antibody Mogamulizumab Predicts a Molecular Response to Disease and Durable Clinical Remission in Leukaemic Subtypes of Adult T-Cell Leukaemia/Lymphoma

Lucy B Cook, MB BS, PhD, Aileen G Rowan, PhD, Maria Antonietta Demontis, PhD, Sasha Marks, MB BS, PhD, Charles R. M. Bangham, Paul Fields, MD PhD, Graham P. Taylor, MD DSc

Blood (2016) 128 (22): 5356.

https://doi.org/10.1182/blood.V128.22.5356.5356

Published: 2016

Journal Articles

A Prospective, Multicenter, Randomized Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Investigator's Choice in the Treatment of Patients with Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma: Overall Response Rate, Progression-Free Survival, and Overall Survival

Blood (2016) 128 (22): 4159.

https://doi.org/10.1182/blood.V128.22.4159.4159

Published: 2016

Journal Articles

Real-Time Molecular Classification of Diffuse Large B-Cell Lymphoma (DLBCL) By Gene Expression Profiling (GEP): Successful Delivery of a Routine Service for Randomization of Patients Onto the Multicenter Remodl-B Trial (ISRCTN 51837425)

Barrans Sharon, PhD, Andrew J Davies, MRCP, Ming Wang, Ming-Qing Du, MB, PhD, Christoph Mamot, MD, Keith Pugh, PhD, Josh Caddy, Matthew A Care, PhD, Jan Taylor, Reuben M Tooze, PhD FRCP, Tom Maishman, Louise Stanton, PhD, Debbie Hamid, Andrew McMillan, PhD, Paul Fields, MD PhD, Andrew Jack, PhD MB, Peter Johnson, MD

Blood (2015) 126 (23): 331.

https://doi.org/10.1182/blood.V126.23.331.331

Published: 2015

Journal Articles

Achievement of Complete Hematological Remission and Reversal of High HTLV-1 Viral Loads with Anti CCR-4 Monoclonal Antibody Administration in Afro Caribbean Patients with Relapsed Chronic Adult T Cell Leukaemia (ATLL)

Paul Fields, MD PhD, Maria Demontis, PhD, Lucy Cook, MD PhD, Sasha Marks, MDFRCPath,FRCP, David Wrench, MD PhD, Arief Gunawan, MBChB, MRCP, Claire Woodley, RN, Graham Taylor, MD FRCP

Blood (2014) 124 (21): 5474.

https://doi.org/10.1182/blood.V124.21.5474.5474

Published: 2014

Journal Articles

A Phase II Open-Label, Multi-Center Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab (KW-0761) in Patients with Previously Treated Peripheral T-Cell Lymphoma(PTCL)

Pier Luigi Zinzani, Bertrand Coiffier, MD PhD, John Radford, Dolores Caballero, Paul Fields, MD PhD, Martine ED Chamuleau, MD, Francesco d'Amore, Corinne Haioun, MD PhD, Catherine Thieblemont, MD PhD, Eva González Barca, MD PhD, Carlos Grande García, MD, Peter W Johnson, MD, Gustaaf W van Imhoff, MD PhD, Andrew Saunders, MD, Karen Dwyer, Franck Morschhauser, MD PhD

Blood (2014) 124 (21): 1763.

https://doi.org/10.1182/blood.V124.21.1763.1763

Published: 2014

Journal Articles

Outcome Of Patients With HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma (ATL) Who Have Undergone Stem Cell Transplantation: A Retrospective Study Of The EBMT Lymphoma Working Party

Ali Bazarbachi, MD, PhD, Kate Cwynarski, Ariane Boumendil, PhD, Herve Finel, Paul Fields, MD, PhD, Kavita Raj, MD, PhD, MRCP, FRCPath, Arnon Nagler, MD, MSc, Mohamad Mohty, MD, PhD, Anna Sureda, MD, Peter Dreger, MD, Olivier Hermine, MD, PhD

Blood (2013) 122 (21): 3398.

https://doi.org/10.1182/blood.V122.21.3398.3398

Published: 2013

Journal Articles

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era,

Silvia Montoto, MD, Kate Shaw, Jessica Okosun, Shreyans Gandhi, Paul Fields, MD, PhD, Andrew Wilson, Milensu Shanyinde, Kate Cwynarski, Robert E. Marcus, MBBS, FRCP, FRCPath, Johannes de Vos, Anna Marie Young, Melinda Tenant-Flowers, FRCP MSc, Chloe Orkin, Margaret Johnson, Daniella Chilton, John G. Gribben, MD, DSc, Mark Bower, MD

Blood (2011) 118 (21): 3646.

https://doi.org/10.1182/blood.V118.21.3646.3646

Published: 2011

Journal Articles

First Analysis of a Phase II Study of Rituximab-Gemcitabine, Cyclophosphamide, Vincristine and Prednisolone (R-GCVP) for Diffuse Large B Cell Lymphoma (DLBCL) Patients Considered Unsuitable for Anthracycline Containing Chemo-Immunotherapy. An NCRI Lymphoma Clinical Studies Group Trial

Paul Fields, MD, PhD, Andrew Webb, MD, Christopher FE Pocock, MD, PhD, William Townsend, Paul Smith, Amy Kirkwood, Nadjet El-Mehidi, PhD, Peter W Johnson, MD, John Radford, MD, David C Linch, MD FMedSci, David Cunningham, MD

Blood (2011) 118 (21): 1634.

https://doi.org/10.1182/blood.V118.21.1634.1634

Published: 2011

Journal Articles

Incidence, Pattern and Clinical Correlation of Bone Marrow Involvement In Adult T-Cell Leukaemia/Lymphoma (ATLL)

Andrew Hodson, MD, Meenal Gupta, MD, Graham Taylor, MD, Paul Fields, MD, PhD, Jon van Der Walt, Mufaddal Moonim

Blood (2010) 116 (21): 5085.

https://doi.org/10.1182/blood.V116.21.5085.5085

Published: 2010

Journal Articles

Addition of Anti-Viral Therapy to Chemotherapy Improves Overall Survival In Acute and Lymphomatous Adult T-Cell Leukaemia/Lymphoma (ATLL)

Andrew Hodson, MD, Silvia Montoto, MD, Naheed Mir, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Kate Cwynarski, MD, PhD, Kirit M Ardeshna, MD, Thurai Kumaran, MD, Estella Matutes, MD, PhD, Graham Talyor, MD, Paul Fields, MD, PhD

Blood (2010) 116 (21): 3961.

https://doi.org/10.1182/blood.V116.21.3961.3961

Published: 2010

Journal Articles

Smouldering Adult T-Cell Leukaemia/Lymphoma (ATLL) Is Not Associated with An Increased Risk of Aggressive ATLL In HTLV-1 Positive Patients

Andrew Hodson, MD, Barbara Bain, FRCPath, MB, Paul Fields, MD, PhD, Graham Talyor, MD

Blood (2010) 116 (21): 4167.

https://doi.org/10.1182/blood.V116.21.4167.4167

Published: 2010

NARROW

HTLV-1 Proviral Load after Two Months' Treatment with Anti-CCR4 Monoclonal Antibody Mogamulizumab Predicts a Molecular Response to Disease and Durable Clinical Remission in Leukaemic Subtypes of Adult T-Cell Leukaemia/Lymphoma

A Prospective, Multicenter, Randomized Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Investigator's Choice in the Treatment of Patients with Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma: Overall Response Rate, Progression-Free Survival, and Overall Survival

Real-Time Molecular Classification of Diffuse Large B-Cell Lymphoma (DLBCL) By Gene Expression Profiling (GEP): Successful Delivery of a Routine Service for Randomization of Patients Onto the Multicenter Remodl-B Trial (ISRCTN 51837425)

Achievement of Complete Hematological Remission and Reversal of High HTLV-1 Viral Loads with Anti CCR-4 Monoclonal Antibody Administration in Afro Caribbean Patients with Relapsed Chronic Adult T Cell Leukaemia (ATLL)

A Phase II Open-Label, Multi-Center Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab (KW-0761) in Patients with Previously Treated Peripheral T-Cell Lymphoma(PTCL)

Outcome Of Patients With HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma (ATL) Who Have Undergone Stem Cell Transplantation: A Retrospective Study Of The EBMT Lymphoma Working Party

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era,

First Analysis of a Phase II Study of Rituximab-Gemcitabine, Cyclophosphamide, Vincristine and Prednisolone (R-GCVP) for Diffuse Large B Cell Lymphoma (DLBCL) Patients Considered Unsuitable for Anthracycline Containing Chemo-Immunotherapy. An NCRI Lymphoma Clinical Studies Group Trial

Incidence, Pattern and Clinical Correlation of Bone Marrow Involvement In Adult T-Cell Leukaemia/Lymphoma (ATLL)

Addition of Anti-Viral Therapy to Chemotherapy Improves Overall Survival In Acute and Lymphomatous Adult T-Cell Leukaemia/Lymphoma (ATLL)

Smouldering Adult T-Cell Leukaemia/Lymphoma (ATLL) Is Not Associated with An Increased Risk of Aggressive ATLL In HTLV-1 Positive Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only